Answers are grounded in this paper and cite their sources.
Pharmacovigilance study reveals adverse event profiles for vinca alkaloids in cancer treatment, highlighting reporting differences between vinorelbine and vincristine.
Vinca alkaloids are widely used in cancer treatment for their ability to target microtubule dynamics. While their efficacy in treating certain cancers is well-established, the full spectrum of their adverse event profiles remains an area of ongoing research.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: